公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma | ZHONG-ZHE LIN ; CHIUN HSU ; YUNG-MING JENG ; Hu F.-C.; Pan H.-W.; YAO-MING WU ; Hsu H.-C.; ANN-LII CHENG | Liver International | 18 | 18 | |
2012 | KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | Lin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | PLoS ONE | 43 | 35 | |
2011 | Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 | SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG | European Journal of Cancer | 17 | 17 | |
2004 | Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines | Ying-Chun Shen ; CHIUN HSU ; Chen J.-Y.; ANN-LII CHENG | British Journal of Cancer | 4 | 5 | |
2011 | Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era | I-CHUN CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; HUANG-CHUN LIEN ; CHIUN HSU ; WEN-HUNG KUO ; YEN-SHEN LU ; ANN-LII CHENG | Breast Cancer Research and Treatment | 84 | 74 | |
2009 | Lamivudine and hepatitis B reactivation | CHIUN HSU ; ANN-LII CHENG ; PEI-JER CHEN | Annals of Internal Medicine | 0 | 0 | |
2017 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy | YU-YUN SHAO ; BANG-BIN CHEN ; DA-LIANG OU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; Wang, M. J.; ANN-LII CHENG ; CHIUN HSU | Alimentary Pharmacology and Therapeutics | 10 | 8 | |
2023 | Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial | Llovet, Josep M; Kudo, Masatoshi; Merle, Philippe; Meyer, Tim; Qin, Shukui; Ikeda, Masafumi; Xu, Ruocai; Edeline, Julien; Ryoo, Baek-Yeol; Ren, Zhenggang; Masi, Gianluca; Kwiatkowski, Mariusz; Lim, Ho Yeong; Kim, Jee Hyun; Breder, Valeriy; Kumada, Hiromitsu; ANN-LII CHENG ; Galle, Peter R; Kaneko, Shuichi; Wang, Anran; Mody, Kalgi; Dutcus, Corina; Dubrovsky, Leonid; Siegel, Abby B; Finn, Richard S | The Lancet. Oncology | 11 | | |
2018 | Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial | Kudo M.; Finn R.S.; Qin S.; Han K.-H.; Ikeda K.; Piscaglia F.; Baron A.; Park J.-W.; Han G.; Jassem J.; Blanc J.F.; Vogel A.; Komov D.; Evans T.R.J.; Lopez C.; Dutcus C.; Guo M.; Saito K.; Kraljevic S.; Tamai T.; Ren M.; ANN-LII CHENG | The Lancet | 3386 | 3008 | |
2021 | Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy | YING-CHUN SHEN ; Yeh C.-P.; YUNG-MING JENG ; CHIUN HSU ; CHIH-HUNG HSU ; ZHONG-ZHE LIN ; YU-YUN SHAO ; LI-CHUN LU ; TSUNG-HAO LIU ; CHIEN-HUNG CHEN ; ANN-LII CHENG | Cancers | 2 | 2 | |
2010 | Liver cancer working group report | Kudo M.; Han K.H.; Kokudo N.; ANN-LII CHENG ; Choi B.I.; Furuse J.; Izumi N.; Park J.-W.; Poon R.T.; Sakamoto M. | Japanese Journal of Clinical Oncology | 54 | 53 | |
2016 | Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy | SHIH-FAN LAI ; YU-HSUAN CHEN ; WEN-HUNG KUO ; HUANG-CHUN LIEN ; Wang M.-Y.; YEN-SHEN LU ; Chiao Lo ; SUNG-HSIN KUO ; ANN-LII CHENG ; CHIUN-SHENG HUANG | Annals of Surgical Oncology | 31 | 28 | |
2014 | Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases | YU-YUN SHAO ; MING-CHIH HO ; ANN-LII CHENG ; CHIH-HUNG HSU | Journal of the Formosan Medical Association | 3 | 3 | |
2008 | Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment | SUNG-HSIN KUO ; Chen L.-T.; MING-SHIANG WU ; CHUNG-WU LIN ; KUN-HUEI YEH ; KUAN-TING KUO ; Yeh P.-Y.; Tzeng Y.-S.; HSIU-PO WANG ; PING-NING HSU ; Lin J.-T.; ANN-LII CHENG | Annals of Surgery | 14 | 13 | |
2005 | Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients | Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; YEN-SHEN LU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN | World Journal of Gastroenterology | 18 | 14 | |
2005 | Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma | Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; HSIU-PO WANG ; SUNG-HSIN KUO ; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG | Journal of the National Cancer Institute | 173 | 135 | |
2022 | Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma | YU-YUN SHAO ; Chen, Pai-Sheng; LIANG-IN LIN ; Lee, Bin-Shyun; Ling, Andrew; ANN-LII CHENG ; CHIUN HSU ; DA-LIANG OU | British journal of cancer | 8 | 10 | |
2020 | Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients | SHIH-HUNG YANG ; JHE-CYUAN GUO ; CHIUN HSU ; SUNG-HSIN KUO ; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH | Journal of the Formosan Medical Association | 3 | 3 | |
2003 | Low-dose thalidomide treatment for advanced hepatocellular carcinoma | CHIUN HSU ; CHIUNG-NIEN CHEN ; Chen L.-T.; Wu C.-Y.; PEI-MING YANG ; Lai M.-Y.; PO-HUANG LEE ; ANN-LII CHENG | Oncology | 87 | 77 | |
1996 | Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue: Clinicopathologic analysis of 19 cases | Chiang I.-P.; Wang H.-H.; ANN-LII CHENG ; Lin J.-T.; Su I.-J. | Journal of the Formosan Medical Association | 9 | 9 | |